AZ-MRC industry partnerships for academic clinicians 2023
Lead Research Organisation:
Imperial College London
Department Name: National Heart and Lung Institute
Abstract
The aim of this scheme is to provide clinically active healthcare professionals currently funded by MRC the opportunity to embed within a major pharmaceutical company, AstraZeneca, in order to gain knowledge and experience of the regulatory and clinical trial processes involved in the development and registration of a new therapy.
Technical Summary
This award provides dedicated time within AstraZeneca to gain experience and exposure in clinical drug development providing a detailed understanding of how to design, initiate, and conduct clinical trials. This may include exposure to the regulatory and ethical considerations and regulations required for clinical trials
People |
ORCID iD |
| Francesca Conway (Principal Investigator / Fellow) |
| Description | AZ-MRC industry partnerships |
| Organisation | Medical Research Council (MRC) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | I was seconded to AstraZeneca for 6 months where I joined the late stage clinical team evaluating biologics in COPD |
| Collaborator Contribution | AstraZeneca and MRC co-funded this opportunity |
| Impact | Attended multidisciplinary meetings with members of clinical, bioinformatics, commercial, medical affairs and regulatory team |
| Start Year | 2023 |